Write a reviewFor vendors
♡
Home / Investors / Lyell Immunopharma

Lyell Immunopharma

South San Francisco · Founded 2018
lyell.com ↗LinkedIn

About Lyell Immunopharma

Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.

Investment focus

Sectors
BioTechLife ScienceHealthcareMedical Device

Portfolio (2 in our database)

Sonoma BioTherapeuticsSonoma BioTherapeutics develops adoptive Treg therapies cell for autoimmune.Series B · $335M raisedEureka TherapeuticsEureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.Series E · $129M raised

Similar investors

Y Combinator

Accelerator · Mountain View · Founded 2005
SeedSeries ASeries BEntertainment & MediaCreator EconomyParentingInformation Technology+88
4441Investments
440Exits

Techstars

Accelerator · Boulder · Founded 2006
Pre-SeedSeedManufacturingAdvertising (AdTech)AgTech (FarmTech)Artificial Intelligence & Machine Learning (AI/ML)+35
3579Investments
367Exits

MassChallenge

Accelerator · Boston, Massachusetts · Founded 2009
BioTechConsumerConsumer ElectronicsBig Data & Analytics+47
3044Investments
160Exits

500 Startups

Venture Fund · San Francisco · Founded 2010
SeedSeries ASeries BFinTechHealthcareInformation TechnologyMarketing (MarTech)+72
2802Investments
337Exits

SOSV

Venture Fund · Princeton · Founded 1994
Pre-SeedSeedSeries AAdvertising (AdTech)AgTech (FarmTech)Artificial Intelligence & Machine Learning (AI/ML)AudioTech+17
2306Investments
57Exits

New Enterprise Associates

Venture Fund · Maryland · Founded 1977
Pre-SeedSeedSeries ASeries BArtificial Intelligence & Machine Learning (AI/ML)Big Data & AnalyticsClimateTech & CleanTechHealthcare+7
2037Investments
551Exits